CEL Total Liab from 2010 to 2024

CVM Stock  USD 0.60  0.10  14.29%   
CEL SCI Total Liabilities yearly trend continues to be very stable with very little volatility. Total Liabilities is likely to grow to about 20.9 M this year. Total Liabilities is the total amount of all liabilities that CEL SCI Corp has, including both short-term and long-term liabilities. View All Fundamentals
 
Total Liabilities  
First Reported
1986-09-30
Previous Quarter
15.7 M
Current Value
15.6 M
Quarterly Volatility
M
 
Black Monday
 
Oil Shock
 
Dot-com Bubble
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check CEL SCI financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among CEL SCI's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4.8 M, Interest Expense of 815.6 K or Selling General Administrative of 5.2 M, as well as many indicators such as Price To Sales Ratio of 717, Dividend Yield of 0.0025 or PTB Ratio of 3.6. CEL financial statements analysis is a perfect complement when working with CEL SCI Valuation or Volatility modules.
  
Check out the analysis of CEL SCI Correlation against competitors.

Latest CEL SCI's Total Liab Growth Pattern

Below is the plot of the Total Liab of CEL SCI Corp over the last few years. It is the total amount of all liabilities that a company has, including both short-term and long-term liabilities. CEL SCI's Total Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in CEL SCI's overall financial position and show how it may be relating to other accounts over time.
Total Liab10 Years Trend
Slightly volatile
   Total Liab   
       Timeline  

CEL Total Liab Regression Statistics

Arithmetic Mean16,704,620
Geometric Mean12,592,776
Coefficient Of Variation48.63
Mean Deviation6,480,434
Median19,335,739
Standard Deviation8,122,793
Sample Variance66T
Range29.2M
R-Value0.63
Mean Square Error42.6T
R-Squared0.40
Significance0.01
Slope1,148,730
Total Sum of Squares923.7T

CEL Total Liab History

202420.9 M
202319.9 M
202217.3 M
202118.4 M
202019.3 M
201920.8 M
201822.5 M

About CEL SCI Financial Statements

CEL SCI investors utilize fundamental indicators, such as Total Liab, to predict how CEL Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Liabilities19.9 M20.9 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CEL SCI Corp is a strong investment it is important to analyze CEL SCI's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CEL SCI's future performance. For an informed investment choice regarding CEL Stock, refer to the following important reports:
Check out the analysis of CEL SCI Correlation against competitors.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.52)
Revenue Per Share
0.001
Quarterly Revenue Growth
(0.63)
Return On Assets
(0.61)
Return On Equity
(2.50)
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.